Joel McIntosh

Person

Pacifica, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bifunctional compounds for degrading BTK via ubiquitin proteosome p...
- Patent number 11,866,442
- Issue date Jan 9, 2024
- NURIX THERAPEUTICS, INC.
- Daniel W. Robbins
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bifunctional compounds for degrading BTK via ubiquitin proteosome p...
- Patent number 11,479,556
- Issue date Oct 25, 2022
- NURIX THERAPEUTICS, INC.
- Daniel W. Robbins
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of integrin alpha 5 beta 1 and methods of use
- Patent number 10,836,720
- Issue date Nov 17, 2020
- The Regents of the University of California
- Dean Sheppard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-alphavbeta1 integrin inhibitors and methods of use
- Patent number 10,214,522
- Issue date Feb 26, 2019
- The Regents of the University of California
- William F. DeGrado
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,593,129
- Issue date Mar 14, 2017
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
- Patent number 9,376,425
- Issue date Jun 28, 2016
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,296,736
- Issue date Mar 29, 2016
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of bruton's tyrosine kinase
- Patent number 8,822,457
- Issue date Sep 2, 2014
- Roche Palo Alto LLC
- Nolan James Dewdney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of bruton's tyrosine kinase
- Patent number 8,618,098
- Issue date Dec 31, 2013
- Roche Palo Alto LLC
- Nolan James Dewdney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of bruton's tyrosine kinase
- Patent number 8,124,604
- Issue date Feb 28, 2012
- Roćhe Palo Alto LLC
- Nolan James Dewdney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of bruton's tyrosine kinase
- Patent number 7,906,509
- Issue date Mar 15, 2011
- Roćhe Palo Alto LLC
- Joshua Kennedy-Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of bruton's tyrosine kinase
- Patent number 7,902,194
- Issue date Mar 8, 2011
- Roche Palo Alto
- Nolan James Dewdney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of Bruton's tyrosine kinase
- Patent number 7,683,064
- Issue date Mar 23, 2010
- Roćhe Palo Alto LLC
- Nolan James Dewdney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Kinase inhibitors and methods for using the same
- Patent number 7,645,764
- Issue date Jan 12, 2010
- Roćhe Palo Alto LLC
- Tobias Gabriel
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20240300892
- Publication date Sep 12, 2024
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME P...
- Publication number 20240124475
- Publication date Apr 18, 2024
- Nurix Therapeutics, Inc.
- Daniel W. ROBBINS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING OR DEGRADING TARGET PROTEINS, COMPOSITIONS...
- Publication number 20230158151
- Publication date May 25, 2023
- Nurix Therapeutics, Inc.
- Eric Wegryzniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME P...
- Publication number 20230029378
- Publication date Jan 26, 2023
- Nurix Therapeutics, Inc.
- Daniel W. ROBBINS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20210179560
- Publication date Jun 17, 2021
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INTEGRIN ALPHA 5 BETA 1 AND METHODS OF USE
- Publication number 20190144386
- Publication date May 16, 2019
- The Regents of the University of California
- Dean Sheppard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20190062276
- Publication date Feb 28, 2019
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20170144971
- Publication date May 25, 2017
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-ALPHAVBETA1 INTEGRIN INHIBITORS AND METHODS OF USE
- Publication number 20160264566
- Publication date Sep 15, 2016
- The Regents of the University of California
- William F. DeGrado
- G01 - MEASURING TESTING
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20160137667
- Publication date May 19, 2016
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140315895
- Publication date Oct 23, 2014
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF BRUTON'S TYROSINE KINASE
- Publication number 20140194413
- Publication date Jul 10, 2014
- Roche Palo Alto LLC
- Nolan James Dewdney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140011796
- Publication date Jan 9, 2014
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of Bruton's Tyrosine Kinase
- Publication number 20120129845
- Publication date May 24, 2012
- Nolan James Dewdney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20110319378
- Publication date Dec 29, 2011
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of Bruton's Tyrosine Kinase
- Publication number 20110105479
- Publication date May 5, 2011
- Nolan James Dewdney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of Bruton's Tyrosine Kinase
- Publication number 20090318448
- Publication date Dec 24, 2009
- Roche Palo Alto LLC.
- Nolan James Dewdney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of Bruton's tyrosine kinase
- Publication number 20090306041
- Publication date Dec 10, 2009
- Roche Palo Alto LLC.
- Nolan James Dewdney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Kinase inhibitors and methods for using the same
- Publication number 20080132528
- Publication date Jun 5, 2008
- Roche Palo Alto LLC.
- Tobias Gabriel
- C07 - ORGANIC CHEMISTRY

Joel McIntosh

Person

Patents Grantslast 30 patents

Bifunctional compounds for degrading BTK via ubiquitin proteosome p...

Bifunctional compounds for degrading BTK via ubiquitin proteosome p...

Inhibitors of integrin alpha 5 beta 1 and methods of use

Anti-alphavbeta1 integrin inhibitors and methods of use

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Inhibitors of bruton's tyrosine kinase

Inhibitors of bruton's tyrosine kinase

Inhibitors of bruton's tyrosine kinase

Inhibitors of bruton's tyrosine kinase

Inhibitors of bruton's tyrosine kinase

Inhibitors of Bruton's tyrosine kinase

Kinase inhibitors and methods for using the same

Patents Applicationslast 30 patents

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME P...

COMPOUNDS FOR INHIBITING OR DEGRADING TARGET PROTEINS, COMPOSITIONS...

BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME P...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

INHIBITORS OF INTEGRIN ALPHA 5 BETA 1 AND METHODS OF USE

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

ANTI-ALPHAVBETA1 INTEGRIN INHIBITORS AND METHODS OF USE

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

INHIBITORS OF BRUTON'S TYROSINE KINASE

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

Inhibitors of Bruton's Tyrosine Kinase

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

Inhibitors of Bruton's Tyrosine Kinase

Inhibitors of Bruton's Tyrosine Kinase

Inhibitors of Bruton's tyrosine kinase

Kinase inhibitors and methods for using the same